Recent progress and current problems in treatment of invasive fungal infection sin neutropenic patients

被引：106

作者：

Walsh, TJ

Hiemenz, JW

Anaissie, E

机构：

[1] UNIV TEXAS, MD ANDERSON CANC CTR, INFECT DIS SECT, HOUSTON, TX 77030 USA

[2] H LEE MOFFITT CANC CTR & RES INST, DIV BONE MARROW TRANSPLANTAT, TAMPA, FL USA

[3] H LEE MOFFITT CANC CTR & RES INST, DIV INFECT TRANSPLANTAT, TAMPA, FL USA

[4] H LEE MOFFITT CANC CTR & RES INST, DIV TROP MED, TAMPA, FL USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 1996年 / 10卷 / 02期

关键词：

D O I：

10.1016/S0891-5520(05)70303-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patients who are receiving cytotoxic chemotherapy for neoplastic diseases, including those receiving allogeneic bone marrow transplantation, are predisposed to develop invasive fungal infections as the result of host defense impairments due to intensive cytotoxic chemotherapy, ablative radiation therapy, corticosteroids, cyclosporine, and the underlying neoplastic process. This article reviews the current approaches and problems in diagnosis, treatment, and prevention of invasive fungal infections in neutropenic patients.

引用

收藏

页码：365 / +

页数：1

相关论文

共 185 条

[1] PULMONARY CRYPTOCOCCOSIS PRESENTING AS METASTASES IN CHILDREN WITH SARCOMAS [J].

ALLENDE, M ;

PIZZO, PA ;

HOROWITZ, M ;

PASS, HI ;

WALSH, TJ .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1993, 12 (03) :240-243

[2] DOSE-DEPENDENT ANTIFUNGAL ACTIVITY AND NEPHROTOXICITY OF AMPHOTERICIN-B COLLOIDAL DISPERSION IN EXPERIMENTAL PULMONARY ASPERGILLOSIS [J].

ALLENDE, MC ;

LEE, JW ;

FRANCIS, P ;

GARRETT, K ;

DOLLENBERG, H ;

BERENGUER, J ;

LYMAN, CA ;

PIZZO, PA ;

WALSH, TJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :518-522

[3] POPULATION PHARMACOKINETICS AND RENAL FUNCTION-SPARING EFFECTS OF AMPHOTERICIN-B COLLOIDAL DISPERSION IN PATIENTS RECEIVING BONE-MARROW TRANSPLANTS [J].

AMANTEA, MA ;

BOWDEN, RA ;

FORREST, A ;

WORKING, PK ;

NEWMAN, MS ;

MAMELOK, RD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) :2042-2047

[4] FLUCONAZOLE THERAPY FOR CHRONIC DISSEMINATED CANDIDIASIS IN PATIENTS WITH LEUKEMIA AND PRIOR AMPHOTERICIN-B THERAPY [J].

ANAISSIE, E ;

BODEY, GP ;

KANTARJIAN, H ;

DAVID, C ;

BARNETT, K ;

BOW, E ;

DEFELICE, R ;

DOWNS, N ;

FILE, T ;

KARAM, G ;

POTTS, D ;

SHELTON, M ;

SUGAR, A .

AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02) :142-150

[5] THE EMERGING ROLE OF FUSARIUM INFECTIONS IN PATIENTS WITH CANCER [J].

ANAISSIE, E ;

KANTARJIAN, H ;

RO, J ;

HOPFER, R ;

ROLSTON, K ;

FAINSTEIN, V ;

BODEY, G .

MEDICINE, 1988, 67 (02) :77-83

[6] AZOLE THERAPY FOR TRICHOSPORONOSIS - CLINICAL-EVALUATION OF 8 PATIENTS, EXPERIMENTAL-THERAPY FOR MURINE INFECTION, AND REVIEW [J].

ANAISSIE, E ;

GOKASLAN, A ;

HACHEM, R ;

RUBIN, R ;

GRIFFIN, G ;

ROBINSON, R ;

SOBEL, J ;

BODEY, G .

CLINICAL INFECTIOUS DISEASES, 1992, 15 (05) :781-787

[7] OPPORTUNISTIC MYCOSES IN THE IMMUNOCOMPROMISED HOST - EXPERIENCE AT A CANCER CENTER AND REVIEW [J].

ANAISSIE, E .

CLINICAL INFECTIOUS DISEASES, 1992, 14 :S43-S53

[8]

ANAISSIE E, 1989, REV INFECT DIS, V11, P369

[9]

Anaissie E, 1993, Recent Results Cancer Res, V132, P137

[10]

ANAISSIE E, IN PRESS AM J MED

← 1 2 3 4 5 6 7 8 9 10 →